Asia Pacific Blood Group Typing Market

Asia Pacific Blood Group Typing Market Size

The size of the Asia Pacific blood group typing market was valued at USD 0.56 billion in 2025, is estimated to reach USD 0.62 billion in 2026, and is projected to reach USD 1.47 billion by 2034, growing at a CAGR of 11.31% from 2026 to 2034.

MARKET DRIVERS

The increasing number of blood donation activities and the increasing incidence of trauma, accidents and surgeries requiring blood transfusion are expected to drive the blood group market for years to come. In addition, the growing demand for blood groups in prenatal and post natal testing and the stringency of prudent blood transfusions await a market boost in the years to come. In addition, the growing importance of forensic studies and blood group requirements in forensic studies and examinations is expected to drive the market over the anticipated period.

The growing number of donated blood and the growing number of patients requiring transfusions due to accidents and trauma are the major factors driving the blood group market. Blood group is also crucial in detecting the condition of hemolytic disease of the newborn (HDN) in pregnant women, thus driving the demand for such tests.

The advent of new molecular diagnostic tools that facilitate rapid and reliable group identification in a large blood sample is expected to provide many opportunities for market players. For example, molecular genotyping of ABO blood groups in large populations can be performed using these methods. Identifying the blood group is also important for genetic disorders for neonates, as it prevents the newborn from being exposed to anemia. The Asia Pacific blood group market has experienced increased growth due to technological advancements in the healthcare industry.

The increasing identification of the disease at an early stage has increased the use of the antibody detection test. This in turn will provide more opportunities for blood group typing in Asia Pacific region.

MARKET RESTRAINTS

Lack of awareness and lack of trained professionals are likely to act as market constraints.

Unfortunately, the COVID-19 epidemic has led to a drastic drop in voluntary blood donation around the world, due to fears over the safety standards of the equipment used and the imposition of closures in most countries. This is challenging market growth rate in upcoming years.

REPORT COVERAGE

REGIONAL ANALYSIS

The Asia region is expected to grow with the highest CAGR due to an increase in the number of traffic accidents and injuries and an increase in the incidence of infectious diseases in this region. For example, according to the WHO, blood donations increased from 2015 to 2019, with 70 million blood donations from unpaid voluntary donors reported between 2015 and 2019. The increase in the number of blood donations and transfusions has thus contributed to the growth of the blood typing market.

 The impressive growth rate of the Asia Pacific blood group market is driven by promising clinical studies on high-throughput devices, increasing healthcare spending, and increasing number of blood transfusions. in India, the Rotary Blood Bank and the Indian Red Cross said they faced a shocking 82% deficit in blood collection. Such sudden drops in blood donation are likely to have unfathomable effects on patients with conditions such as thalassemia and hemophilia, which require regular blood transfusions. As the efficiency of blood typing mechanisms is highly dependent on blood donation, a decline in these activities will have a negative impact on the growth of the blood typing market.

KEY MARKET PLAYERS

Top Companies leading the Asia Pacific Blood Group Typing Market Profiled in the Report are Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, BAG Healthcare GmbH, Rapid Labs, Day medical SA, DIAGAST, and AXO Science.

MARKET SEGMENTATION

This research report on the Asia Pacific Blood Group Typing Market has been segmented and sub-segmented into the following categories.

By Product

• Consumables

  • Antisera Reagents

  • Red Blood Cell Reagents

  • Anti-Human Globulin Reagents

  • Blood Bank Saline

• Instrument

• Services

By Test Type

• ABO
• Antigen
• Antibody Screening
• Cross Matching
• HLA

By Technique

• Assay
• PCR
• Microarray
• Massively Parallel Sequencing

By End User

• Hospitals
• Clinical Laboratories
• Blood Banks

By Country

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of Asia Pacific